Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hand Surg Rehabil ; 42(1): 86-89, 2023 02.
Artigo em Inglês | MEDLINE | ID: mdl-36336266

RESUMO

We report two cases of metacarpal arch disruption after Motec® total wrist arthroplasty, with hyperextension of the third metacarpal and dorsal protrusion of the head. Correction osteotomies of the adjacent metacarpals using preoperative 3D surgical planning were successful. This report seeks to shed light on the origin of this deformation and to recommend some operative precautions. It is important that surgeons should be aware of the existence of this complication, as disruption of the transverse metacarpal arch affects both grasp and hand esthetics. LEVEL OF EVIDENCE: IV.


Assuntos
Prótese Articular , Ossos Metacarpais , Humanos , Ossos Metacarpais/cirurgia , Punho , Mãos , Osteotomia
2.
Hand Surg Rehabil ; 41(6): 701-706, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-36087874

RESUMO

Acute calcium deposit (ACD) in the hand and wrist is a cause of acute pain due to crystal-induced soft-tissue inflammation. There are no standard management guidelines for this condition, which is frequently treated with non-steroidal anti-inflammatory drugs (NSAIDs), with variable efficacy, some patients presenting symptoms for several months. We retrospectively analyzed the results of all patients treated with anakinra for hand or wrist ACD in our department in 2020. We extracted data on treatment duration, pain, range of motion, skin erythema, hypervascularization, edema, and X-ray findings. Ten patients were treated for hand or wrist ACD with anakinra 100 mg per day for a mean 2.7 days. We observed rapid and significant improvement in pain, range of motion, local erythema and edema from day 2 and a decrease in skin temperature from day 3. Calcifications significantly decreased in size or disappeared in the majority of the patients. There were no adverse events or recurrences at 1 year's follow-up. Anakinra was associated with significant clinical improvement after only two days' treatment and may be considered to treat patients with hand or wrist ACD, especially in case of contraindications to NSAIDs or glucocorticoids. Further controlled studies are needed to confirm the present observations.


Assuntos
Proteína Antagonista do Receptor de Interleucina 1 , Punho , Humanos , Proteína Antagonista do Receptor de Interleucina 1/uso terapêutico , Cálcio , Estudos Retrospectivos , Anti-Inflamatórios não Esteroides/uso terapêutico , Dor
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...